Market Trends of Global Oxytocin Industry
This section covers the major market trends shaping the Oxytocin Market according to our research experts:
Antepartum Segment is Expected to Witness Growth Over the Forecast Period
Antepartum oxytocin injection (synthetic) is indicated for initiating or improving uterine contractions, where it is desirable and considered suitable to achieve early vaginal delivery for fetal or maternal reasons. In the antepartum period, exogenous oxytocin is the United States Food and Drug Administration (FDA) approved for strengthening uterine contractions with the aim of successful vaginal delivery of the fetus.
Research and development, product launches, mergers, and acquisitions in the studied segment boost the market growth. For instance, as per the article published in May 2020 under the title 'Augmentation of Labor With Oxytocin and its Association With Delivery Outcomes: A Large-Scale Cohort Study in 12 Public Hospitals in Nepal', the augmentation of labor with oxytocin was associated with beneficial effects, such as improved monitoring and a decreased risk of cesarean section. Proper use of oxytocin was needed to augment labor in low-resource contexts and call for evidence-based guidelines on the augmentation of labor in low-resource settings.
Moreover, according to the article titled 'The Role of Oxytocin and the Effect of Stress During Childbirth: Neurobiological Basics and Implications for Mother and Child,' published in October 2021 stated that, during pregnancy, childbirth, and beyond, the neuropeptide oxytocin is essential for maintaining the health and safety of mother and child. It is a neuromodulator in the central nervous and periphery through endocrine and paracrine pathways.
Hence as per the factors above, the Antepartum segment will likely face growth over the forecast period.
North America is Expected to Dominate the Oxytocin Market
North America dominates the oxytocin products market, due to the increasing number of preterm births, fertility rates, and increasing healthcare expenditure. For instance, according to the Centers for Disease Control and Prevention (CDC), 'Births: Provisional Data for 2021' report, the number of births in the United States and the general fertility rate increased for the first time in seven years in 2021. The report shows a 1% increase in births from 2020, with 3,659,289 births recorded in 2021. As per the same source, the preterm birth rate rose 4% in 2021 to 10.48%, from 10.09% in 2020. During antepartum oxytocin helps in strengthening uterine contractions with the aim of successful vaginal delivery of the fetus. Since oxytocin is indicated and approved in both the antepartum and postpartum period the market is likely to grow due to the increase in the number of births in the studied region.
Moreover, the number of live births and pregnancy complications in Mexico and Canada regions are also fuelling factors for the market growth. For instance, as per the 'National Vital Statistics Reports' published in February 2022, the percentages of unmarried births ranged from about one in five births in Utah (19.3%) to more than one in two births in Louisiana (54.5%), Mississippi (55.8%), and New Mexico (53.2%) in 2020. Hence varied birth populations in the different regions of North America are anticipated to boost the market growth over the forecast period.
Furthermore, the government initiative to provide more information and awareness to people regarding the use of Oxytocin fuels the market growth. For instance, the 2021 report from SafeMedicationUse.ca with the support of Health Canada released a handout titled 'Oxytocin to Start or Advance Labour: 5 Questions to Ask', which describes the benefits and risks of oxytocin and was able to help pregnant individuals and their support person have conversations with their health care team. Hence people are likely to get familiar with the usage of Oxytocin and thus boosting the market growth.
As per the factors mentioned above, North America is expected to witness growth over the forecast period.
